Behandling med nukleosidanaloger skal seponeres, hvis der forekommer hurtigt stigende aminotransferaseniveauer, progressiv hepatomegali eller metabolisk acidose/ laktatacidose af ukendt ætiologi.
Treatment with nucleoside analogues should be discontinued when rapidly elevating aminotransferase levels, progressive hepatomegaly or metabolic/ lactic acidosis of unknown aetiology occur.